We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Simple MRI Scan Can Predict Radiation Side Effects for Prostate Cancer

By HospiMedica International staff writers
Posted on 20 Oct 2023

Radiation therapy is frequently used to treat prostate cancer and is generally considered safe for patients. More...

However, some men do suffer from side effects that can negatively affect their quality of life for certain periods. Until now, it has been difficult for researchers to pinpoint specific risk factors that could indicate who is more likely to experience these side effects post-radiation. Now, a simple MRI scan and unique metric to determine urethra length may offer some insights.

A new study by Corewell Health (Southfield, MI, USA) has shown a correlation between the length of the prostatic urethra, which is the section of the urethra that passes through the prostate, and the risk of experiencing urinary side effects after undergoing radiation treatment for prostate cancer. According to their analysis of data gathered from 361 men, each 1-centimeter increase in the length of the prostatic urethra was associated with a roughly 60% increase in urinary issues like frequent urination and urgency. Men with a prostatic urethra length exceeding 4.6 centimeters were nearly twice as likely to develop these symptoms.

What makes this study noteworthy is the lack of known risk factors that can predict who will face side effects after radiation therapy for prostate cancer. In this study, neither the type of radiation used nor any existing medical conditions were linked to the development of symptoms. This highlights the difficulty researchers have faced in identifying risk factors in the past and emphasizes the potential value of employing MRI technology in the care and treatment of prostate cancer.

“Our novel MRI metric may help patients know beforehand what their risk is in developing these symptoms and help them make better and more informed decisions on a course of treatment that optimizes quality of life,” said Kiran Nandalur, M.D., principal investigator of the study and a radiologist at Corewell Health.

Related Links:
Corewell Health 


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hypodermic Syringe
SurTract™ Safety Syringe
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.